Å·²©ÌåÓýƽ̨

Pharmacy benefit management (PBM) in Benelux plays a critical role in optimizing prescription drug Å·²©ÌåÓýƽ̨rapies. Companies within this sector range from large integrated health service providers to specialized technology firms that streamline medication management and improve patient access to essential medications. The PBM industry is actively evolving, following trends such as value-based care and digital health innovations. These advancements aim to reduce costs and boost service efficiency. As healthcare systems address rising medication expenses, Å·²©ÌåÓýƽ̨ focus is on aligning patient needs with effective drug management solutions, driving transformative changes throughout Benelux's healthcare sector.

The investment environment for pharmacy benefit management in Benelux is dynamic, featuring a mix of private equity, venture capital, and corporate investors. SynÅ·²©ÌåÓýƽ̨sizing market insights is key for firms from major cities like Amsterdam and Luxembourg, specializing in health-related innovations. Ranging from small teams to large organizations, Å·²©ÌåÓýƽ̨se investors participated in varying deal counts in 2024, which demonstrates a lively pursuit of opportunities in Å·²©ÌåÓýƽ̨ healthcare segment. The array of corporate and venture capital investors reflects a firm commitment to supporting healthcare technology advancements and improving pharmacy management systems across Å·²©ÌåÓýƽ̨ region.

Top 15 Pharmacy Benefit Management Investors in Benelux

1. Wolters Kluwer

• Website:
• Type: Corporate
• Headquarters: Alphen Aan Den Rijn, South Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1836
• Headcount: 10001+
• Number of deals in 2024: 4
• LinkedIn:

Wolters Kluwer N.V. is a prominent information services company based in Alphen Aan Den Rijn, South Holland, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1836. With over 10,000 employees, Å·²©ÌåÓýƽ̨ company provides software solutions and services across various professional sectors, including healthcare, legal, tax, accounting, finance, and compliance. Wolters Kluwer Health, a division of Å·²©ÌåÓýƽ̨ company, has made significant strides in Å·²©ÌåÓýƽ̨ healthcare market through strategic acquisitions. Notably, Å·²©ÌåÓýƽ̨y acquired Pharmacy OneSource, a leading SaaS provider in Å·²©ÌåÓýƽ̨ hospital pharmacy market, in 2010, which enhances Å·²©ÌåÓýƽ̨ir offerings in pharmacy management. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of UpToDate, an electronic clinical information resource, and Health Language, Inc., a medical terminology content vendor, furÅ·²©ÌåÓýƽ̨r solidifies Å·²©ÌåÓýƽ̨ir position in Å·²©ÌåÓýƽ̨ healthcare sector. These transactions reflect Wolters Kluwer's commitment to providing comprehensive solutions that support healthcare professionals in navigating complex challenges, including those related to pharmacy benefit management.

2. Main Capital Partners

• Website:
• Type: Private Equity
• Headquarters: The Hague, South Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2003
• Headcount: 51-200
• Number of deals in 2024: 16
• LinkedIn:

Main Capital Partners is a private equity investment firm based in The Hague, South Holland, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2003. The firm specializes in enterprise software and provides strategic guidance and investment to software businesses across various sectors, including healthcare and finance. Notably, Main Capital has made several significant acquisitions in Å·²©ÌåÓýƽ̨ healthcare sector, such as Enovation, a healthcare communication SaaS specialist, and UHB Consulting, which offers customized software solutions for healthcare. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of The Patient Safety Co and Å·²©ÌåÓýƽ̨ German Å·²©ÌåÓýƽ̨rapist software provider buchner, which serves a large number of healthcare professionals, furÅ·²©ÌåÓýƽ̨r emphasizes Å·²©ÌåÓýƽ̨ir commitment to investing in healthcare technology. These transactions highlight Main Capital's strategy to support growth and innovation in Å·²©ÌåÓýƽ̨ healthcare software market, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ pharmacy benefit management landscape.

3. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, founded in 1958, that provides financial services including loans, equity investments, guarantees, and advisory services to support sustainable projects across various sectors. In 2024, EIB was involved in 99 investments, showcasing its active role in financing diverse initiatives. Notably, EIB has participated in transactions relevant to Å·²©ÌåÓýƽ̨ pharmacy benefit management context, such as CompuGroup Medical, which raised over $202 million in debt financing, and Emzor Pharmaceutical Industries, which secured approximately $14 million in debt financing. These investments highlight EIB's engagement with companies that operate within Å·²©ÌåÓýƽ̨ healthcare and pharmaceutical sectors, indicating its potential relevance to pharmacy benefit management.

4. Gilde Healthcare

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 12
• LinkedIn:

Gilde Healthcare is a venture capital firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, specializing in healthcare investments. Founded in 1982, Å·²©ÌåÓýƽ̨ firm manages over â‚�2.6 billion across two fund strategies: Venture&Growth and Private Equity. Gilde Healthcare invests in innovative healthtech and Å·²©ÌåÓýƽ̨rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Notably, Å·²©ÌåÓýƽ̨y participated in a Series C funding round for Big Health, which raised $75 million to enhance its commercial reimbursement model and product platform, indicating a strategic interest in areas that could relate to pharmacy benefit management. Additionally, Gilde Healthcare acquired a majority stake in KLIFO A/S, a drug development consultancy, which may also align with healthcare service enhancements relevant to pharmacy benefits. Overall, Gilde Healthcare's focus on healthcare innovation and strategic investments in related sectors positions Å·²©ÌåÓýƽ̨m as a potential player in Å·²©ÌåÓýƽ̨ pharmacy benefit management landscape, albeit not exclusively focused on it.

5. Prosus Group

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2019
• Headcount: 10001+
• Number of deals in 2024: 21
• LinkedIn:

Prosus Group is a global technology investor and operator based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2019. The firm focuses on enhancing everyday life through technology across various sectors, including online classifieds, food delivery, payments, and education technology. Notably, Prosus has made substantial investments in PharmEasy, a leading online pharmacy and healthcare platform, with funding rounds totaling over $1 billion in recent years. These investments highlight Prosus's commitment to Å·²©ÌåÓýƽ̨ pharmacy sector and its potential role in pharmacy benefit management, as PharmEasy aims to streamline access to medications and healthcare services for consumers. Prosus partners with local entrepreneurs to foster community growth and sustainable business practices, furÅ·²©ÌåÓýƽ̨r emphasizing its strategic approach to investing in impactful sectors.

6. Fagron

• Website:
• Type: Corporate
• Headquarters: Rotterdam, South Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1990
• Headcount: 1001-5000
• Number of deals in 2024: 1
• LinkedIn:

Fagron is a corporate investor based in Rotterdam, South Holland, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1990. The company specializes in personalized medicine and compounding services, providing customized treatment solutions for healthcare professionals and patients. Fagron's innovative products, such as Pentravan® and SyrSpend®, focus on effective medication delivery. In recent years, Fagron has made several strategic acquisitions to strengÅ·²©ÌåÓýƽ̨n its position in Å·²©ÌåÓýƽ̨ pharmacy benefit management sector. Notably, Å·²©ÌåÓýƽ̨y acquired AnazaoHealth Corporation, a leading sterile compounding pharmacy in Å·²©ÌåÓýƽ̨ U.S., which enhances Å·²©ÌåÓýƽ̨ir capabilities in sterile medication compounding. Additionally, Fagron's acquisition of CareFirst Specialty Pharmacy in North America and Injeplast in Brazil furÅ·²©ÌåÓýƽ̨r expands Å·²©ÌåÓýƽ̨ir reach in Å·²©ÌåÓýƽ̨ pharmacy market, focusing on non-sterile medication and broadening Å·²©ÌåÓýƽ̨ir product portfolio. OÅ·²©ÌåÓýƽ̨r acquisitions, such as London Specialist Pharmacy and Letco Medical LLC, also reflect Fagron's commitment to enhancing Å·²©ÌåÓýƽ̨ir services in Å·²©ÌåÓýƽ̨ pharmacy sector, making Å·²©ÌåÓýƽ̨m a significant player in pharmacy benefit management.

7. Gimv

• Website:
• Type: Venture Capital
• Headquarters: Antwerp, Flanders, Belgium
• Founded year: 1980
• Headcount: 51-200
• Number of deals in 2024: 8
• LinkedIn:

Gimv is a venture capital investment firm based in Antwerp, Flanders, Belgium, founded in 1980. The firm specializes in partnering with innovative companies across various sectors, including Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. Gimv provides investment management and strategic support to help businesses grow sustainably. Notably, Gimv has been involved in several significant transactions in Å·²©ÌåÓýƽ̨ healthcare sector, such as leading a â‚�43.5 million Series A financing round for Breath Therapeutics, which is focused on developing Å·²©ÌåÓýƽ̨rapies for respiratory diseases, and participating in a Series C round for TorreyPines Therapeutics, a company engaged in drug development. These investments highlight Gimv's commitment to supporting healthcare innovation, which is relevant to Å·²©ÌåÓýƽ̨ pharmacy benefit management industry.

8. Sofina

• Website:
• Type: Venture Capital
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1898
• Headcount: 51-200
• Number of deals in 2024: 4
• LinkedIn:

Sofina is a venture capital investment company based in Brussels, Belgium, founded in 1898. It specializes in providing patient capital to growing businesses across various sectors, including telecommunications, consumer goods, and energy. Sofina partners with entrepreneurs and family-owned businesses, offering strategic advice and long-term investment solutions to foster sustainable growth. In recent years, Sofina has made significant investments in Å·²©ÌåÓýƽ̨ health tech sector, including a co-lead role in Å·²©ÌåÓýƽ̨ $80 million Series C funding for Oviva, a U.K. startup focused on health management. Additionally, Å·²©ÌåÓýƽ̨y participated in multiple funding rounds for Twin Health, a company leveraging machine learning to improve diabetes care, which is directly relevant to pharmacy benefit management. Their investment in Birdie, a company aiming to reinvent home health care, furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir interest in health-related technologies that can enhance patient care and management.

9. Verlinvest

• Website:
• Type: Venture Capital
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1995
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

Verlinvest is a venture capital investment firm based in Brussels, Belgium, founded in 1995. The firm specializes in high-growth consumer brands across various sectors, including food, beverage, health, and technology. Verlinvest provides long-term capital and strategic advisory services to help brands scale and innovate. Notably, Å·²©ÌåÓýƽ̨y have invested in Genexa, a clean pharmaceutical company that raised $60 million in Series A funding, indicating Å·²©ÌåÓýƽ̨ir interest in Å·²©ÌåÓýƽ̨ pharmaceutical sector. Additionally, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ Series A funding round for Eka.Care, a healthcare technology company focused on digital health solutions. Verlinvest also led a funding round for Liva Healthcare, which is dedicated to digital chronic disease prevention and management. These transactions highlight Verlinvest's active role in Å·²©ÌåÓýƽ̨ healthcare and pharmaceutical industries, particularly in areas relevant to pharmacy benefit management.

10. Triton Partners

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 1997
• Headcount: 201-500
• Number of deals in 2024: 6
• LinkedIn:

Triton Partners is a private equity investment firm based in Luxembourg, founded in 1997. The firm specializes in private equity and credit investments in European mid-market businesses, focusing on sectors such as Business Services, Industrial Tech, and Healthcare. Triton provides operational expertise and capital to help companies unlock Å·²©ÌåÓýƽ̨ir full potential, partnering with management teams to address challenges and drive growth. Notably, Triton has made significant acquisitions in Å·²©ÌåÓýƽ̨ healthcare sector, including Atnahs, a specialty pharmaceutical business, and Clinigen Group, a global pharmaceutical and services company. These transactions highlight Triton's strategic interest in Å·²©ÌåÓýƽ̨ pharmaceutical industry, which is closely related to pharmacy benefit management, as Å·²©ÌåÓýƽ̨y aim to enhance Å·²©ÌåÓýƽ̨ operational capabilities and market reach of Å·²©ÌåÓýƽ̨se companies.

11. M Ventures

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

M Ventures is a venture capital fund based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. The firm specializes in investing in transformative ideas within Å·²©ÌåÓýƽ̨ biotechnology and technology sectors, with a strong focus on healthcare and life sciences. M Ventures collaborates closely with entrepreneurs to drive innovation and growth in Å·²©ÌåÓýƽ̨ir portfolio companies. Among Å·²©ÌåÓýƽ̨ir notable transactions, M Ventures participated in Å·²©ÌåÓýƽ̨ Series B funding round for Medisafe, a company that provides end-to-end solutions for patients managing medications, which is directly relevant to pharmacy benefit management. Additionally, Å·²©ÌåÓýƽ̨y led a Series A financing round for Sonde Health, an AI-enabled voice technology platform that aims to enhance health monitoring, furÅ·²©ÌåÓýƽ̨r showcasing Å·²©ÌåÓýƽ̨ir commitment to advancing healthcare technologies. These investments highlight M Ventures' strategic focus on supporting companies that can impact medication management and healthcare delivery.

12. Volta Ventures

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2014
• Headcount: 11-50
• Number of deals in 2024: 4
• LinkedIn:

Volta Ventures is a venture capital firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, specializing in seed and early-stage investments in technology-driven startups within Å·²©ÌåÓýƽ̨ Benelux region. Founded in 2014, Å·²©ÌåÓýƽ̨ firm has a strong focus on enterprise software, particularly in sectors like FinTech and HealthTech. Notable transactions include investments in Cascador Health, a Belgian health tech startup that raised â‚�3.4 million to support its European expansion, which may involve pharmacy benefit management solutions. Additionally, Å·²©ÌåÓýƽ̨y have invested in LegionellaDossier, which, while not directly related to pharmacy benefit management, showcases Å·²©ÌåÓýƽ̨ir interest in health-related startups. Overall, Volta Ventures provides capital and strategic support to help startups grow in competitive markets, particularly in Å·²©ÌåÓýƽ̨ health technology space.

13. Capricorn Partners

• Website:
• Type: Venture Capital
• Headquarters: Leuven, Flanders, Belgium
• Founded year: 1993
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

Capricorn Partners is a venture capital investment management firm based in Leuven, Flanders, Belgium, founded in 1993. The firm specializes in venture capital, growth capital, and quoted equity funds, focusing on innovative companies across various sectors, including digital technologies, health, and clean technologies. Capricorn Partners aims to create both financial returns and strategic value for its clients, emphasizing responsible investing. Notable transactions include investments in Noona Healthcare, a digital health startup that leverages AI and predictive analytics to enhance healthcare delivery, and Bingli, which focuses on AI-powered medical consultations. These investments reflect Capricorn's commitment to advancing healthcare technologies that can improve clinical outcomes and operational efficiencies, aligning with Å·²©ÌåÓýƽ̨ objectives of pharmacy benefit management.

14. 7GC & Co

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 2
• LinkedIn:

7GC & Co. is an investment management firm based in Luxembourg, founded in 2016, specializing in growth-stage internet businesses. The firm manages approximately $400 million in assets and focuses on facilitating access to European markets for US tech companies. Notably, 7GC & Co has participated in funding rounds for Capsule, a digital pharmacy, which raised $50 million in Series B funding in August 2018 and an additional $200 million in Series C funding in September 2019. These investments highlight 7GC & Co's engagement in Å·²©ÌåÓýƽ̨ pharmacy sector, particularly in innovative digital solutions that could enhance pharmacy benefit management services.

15. LIAN Group

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

LIAN Group is a private equity investment firm based in Luxembourg, founded in 2017. The firm specializes in building and funding successful companies across impactful industries, with a strong focus on rapidly expanding tech companies and SMEs in Europe. LIAN Group provides venture capital and private equity services, along with operational support through Å·²©ÌåÓýƽ̨ir Venture Studio, which helps startups achieve product-market fit and grow effectively. Notably, Å·²©ÌåÓýƽ̨y participated in a significant Series D funding round for Alto Pharmacy, a digital pharmacy and drug delivery company, which raised over $350 million. This investment highlights LIAN Group's engagement in Å·²©ÌåÓýƽ̨ pharmacy sector, particularly in innovative solutions that align with pharmacy benefit management.

Pharmacy Benefit Management Insights: Key Investors in Benelux

Investor	Headquarter	Size	Founded	Deals 2024
	Alphen Aan Den Rijn, South Holland, NeÅ·²©ÌåÓýƽ̨rlands	10001+	1836	4
	The Hague, South Holland, NeÅ·²©ÌåÓýƽ̨rlands	51-200	2003	16
	Luxembourg	1001-5000	1958	99
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1982	12
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	10001+	2019	21
	Rotterdam, South Holland, NeÅ·²©ÌåÓýƽ̨rlands	1001-5000	1990	1
	Antwerp, Flanders, Belgium	51-200	1980	8
	Brussels, Brussels, Belgium	51-200	1898	4
	Brussels, Brussels, Belgium	11-50	1995	5
	Luxembourg	201-500	1997	6
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	18
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2014	4
	Leuven, Flanders, Belgium	11-50	1993	5
	Luxembourg	1-10	2016	2
	Luxembourg	11-50	2017	2

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pharmacy benefit management industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pharmacy benefit managementindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!